Sofinnova Capital VII FCPR, 10% Owner at Shockwave Medical, Inc. (SWAV), sold 342,142 shares at $45.97 ($16.0M) on 2020-06-09, disclosed to the SEC on 2020-06-11.
Scheduled sale ($16.0M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.97 | 10,544 | $485K | 3.0% |
| 2 | $45.97 | 10,544 | $485K | 3.0% |
| 3 | $46.96 | 121,543 | $5.7M | 35.6% |
| 4 | $46.96 | 121,543 | $5.7M | 35.6% |
| 5 | $47.42 | 9,255 | $439K | 2.7% |
| 6 | $47.42 | 9,255 |
| $439K |
| 2.7% |
| 7 | $46.79 | 29,729 | $1.4M | 8.7% |
| 8 | $46.79 | 29,729 | $1.4M | 8.7% |
| Total | $46.89 avg | 342,142 | $16.0M | 100% |
| Filing → |
| SWAV | SELL | 2020-08-14 | $1.5M | — | Filing → |
| SWAV | SELL | 2020-08-10 | $7.3M | — | Filing → |
| SWAV | SELL | 2020-08-05 | $23.0M | — | Filing → |